Refine your search

Tags
Author
Jurisdiction

731 results found

Article
Ask Lexy

Shook Hardy & Bacon LLP | USA | 13 Nov 2014

Dissatisfied patent reexamination plaintiff contends standing conferred by statute

A consumer-interest organization that was dissatisfied by a Board of Patent Appeals and Interferences (BPAI) ruling in the appeal of a patent…
Article
Ask Lexy

Shook Hardy & Bacon LLP | USA | 13 Nov 2014

Ninth Circuit rules out state’s claims in class settlement with fetal-gender testing co

The Ninth Circuit Court of Appeals has enjoined California's effort to obtain restitution on behalf of individual citizens bound by the bargainedfor…
Article
Ask Lexy

Shook Hardy & Bacon LLP | USA | 13 Nov 2014

Bio-Rad agrees to pay $55 million to resolve SEC bribery charges

A California-based clinical diagnostic and life science research company has reportedly agreed to pay $55 million to resolve U.S. Securities and…
Article
Ask Lexy

Shook Hardy & Bacon LLP | USA | 13 Nov 2014

FTC settles deceptive sales-tactics claims against MPHJ Technology

The U.S. Federal Trade Commission (FTC) has agreed to settle claims that MPHJ Technology Investments, LLC—a patent-assertion entity (PAE)—and company…
Article
Ask Lexy

Shook Hardy & Bacon LLP | USA | 13 Nov 2014

RAND Corp. predicts $44.2 billion in savings with biosimilars

The Rand Corp. has issued a perspective titled "The Cost Savings Potential of Biosimilar Drugs in the United States." It predicts that "biosimilars…
Article
Ask Lexy

Shook Hardy & Bacon LLP | USA | 13 Nov 2014

CNS drug approvals take longer, are rejected more often

A new Tufts Center for the Study of Drug Development report reveals that drugs to treat central nervous system (CNS) disorders take longer to develop…
Article
Ask Lexy

Shook Hardy & Bacon LLP | USA | 13 Nov 2014

College research program partners with diagnostics firm

The Baylor College of Medicine and diagnostics company Miraca Holdings have reportedly formed a joint venture—Baylor Miraca Genetics…
Article
Ask Lexy

Shook Hardy & Bacon LLP | India, USA | 13 Nov 2014

Ranbaxy loses FDA approval for two generics

According to a statement that Ranbaxy Laboratories Ltd. provided to the Bombay Stock Exchange Website, the U.S. Food and Drug Administration (FDA)…
Article
Ask Lexy

Shook Hardy & Bacon LLP | USA | 13 Nov 2014

News bytes

The U.S. Food and Drug Administration (FDA) makes available Guidance for Industry and staff titled "Molecular Diagnostic Instruments with Combined…
Article
Ask Lexy

Shook Hardy & Bacon LLP | USA | 30 Oct 2014

Third Circuit revives shareholder suit over dissolved biotech company

A divided Third Circuit Court of Appeals panel has reversed a district court ruling dismissing a shareholder's lawsuit against individuals and a…
Previous page 1 2 3 ...